Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date Phase I/II Clinical Trials of Axitinib in the Treatment of Melanoma, Hepatocellular Carcinoma and Colorectal CancerResearch Oncology All, USA Advances in Moderate-to-Severe Atopic Dermatitis for DermatologistsRelease Date:Education Inflammation & Immunology USA Incorporating Biosimilar Treatment Options in Solid Tumor Education ProgramsRelease Date:Education Oncology All NSCLC – Current Practice ConsiderationsRelease Date:Education Oncology Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Mexico, Monaco, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, USA, United Kingdom Gram Negatives Pathogens & Antimicrobial Resistance: Local Data Generation in Latin AmericaRelease Date:Research Hospital Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Guatemala, Honduras, Mexico, Panama, Peru, Uruguay Addressing Health Disparities in Inflammatory Bowel DiseaseRelease Date:Quality Improvement Inflammation & Immunology USA Enduring SpA ProgramsRelease Date:Education Inflammation & Immunology All Atopic Dermatitis Patient EducationRelease Date:Education Inflammation & Immunology USA Knowledge Gaps in Updated Pneumococcal Immunization RecommendationsRelease Date:Education Vaccines USA Prostate Cancer Disparities ProjectQuality Improvement Oncology USA Telehealth Solutions in Rheumatoid Arthritis for Improving Education and Patient Care (Emerging Markets)Release Date:Education Inflammation & Immunology All Telehealth Solutions in Atopic Dermatitis for Improving Education and Patient Care (Emerging Markets)Release Date:Education Inflammation & Immunology All